USFDA gives nod to Cipla’s generic product
According to IQVIA (IMS Health), Durezol had US sales of around $106 million for the 12-month period ending June 2021
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cipla
Cipla Q1 net profit rises 25 per cent to Rs 709.92 crores
The company had posted a net profit of Rs 566.04 crores in the corresponding period of the previous fiscal, Cipla said in a filing…
An organisation with a diverse talent pool not only makes for good social sense but also makes for…
Samina Hamied, Executive Vice-Chairperson, Cipla, talks about leading from the front, building an inclusive, diverse and equitable…
Rubicon Research acquires MeditabSpecialities’ facility in Satara, Maharashtra
The facility manufactures oral liquid dosage and nasal products
Cipla, Dr Reddy’s, Emcure, Sun Pharma and Torrent to partner for clinical trial of Molnupiravir
As per the directive of the SEC of the CDSCO, Dr Reddy’s will conduct the clinical trial and the other four pharma companies will…
Cipla gets permission from DCGI to import Moderna’s COVID-19 vaccine
The company has to submit seven days safety assessment of the vaccine in the first 100 beneficiaries before rolling out the…
Cipla gets USFDA nod for inhalation product
The approved product is a generic version of Sunovion Pharmaceuticals Inc's Brovana
Avenue Therapeutics gets complete response letter from USFDA for IV Tramadol
The CRL stated that the delayed and unpredictable onset of analgesia with IV tramadol does not support its benefit as a…
Cipla seeks clarity, guidance from Govt for import of COVID-19 vaccine
The company is seeking fast-track approvals to expeditiously bring Moderna's single-dose COVID-19 booster vaccine into India
Cipla to market Roche’s antibody cocktail pan-India, first batch currently available
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in…